According to foreign media reports, the two star players in artificial intelligence—OpenAI and Anthropic—are taking formal steps toward initial public offerings (IPOs) while accelerating the expansion of AI tools into healthcare, clinical workflows, and life sciences. Sources indicate that Anthropic confidentially submitted a draft S-1 registration statement to the U.S. Securities and Exchange Commission a week ago, proposing an initial public offering of common stock. Meanwhile, OpenAI CEO Sam Altman recently told employees that the company expects to go public within the next year and is targeting a valuation of up to $1 trillion.
In the healthcare segment, the potential IPOs of these two companies will offer a clearer view of how they are monetizing AI tools in regulated environments. These use cases span hospitals, health systems, insurance payers, clinicians, and pharmaceutical companies. Notably, smart ring maker Oura also confidentially filed its S-1 form in May, signaling that AI and digital health companies are aggressively preparing for the capital markets. From clinical decision support to drug discovery, AI giants are steadily penetrating core healthcare functions, and their IPOs will provide a more transparent financial picture of their commercialization pathways.
